Cosciens Biopharma Inc. declined 1.77% in intraday trading, with the company announcing the results of its virtual 2025 annual general and special meeting of shareholders. The company reported the voting results for the election of directors, with Peter H. Puccetti (Chair) receiving 88.92% of the votes in favor.
Comments
No comments yet